文献速递血液透析通路

血液透析动静脉内瘘继发高输出量心力衰竭的转化科学进展

Translational Sciences in Cardiac Failure Secondary to Arteriovenous Fistula in Hemodialysis Patients.
PubMed 文献 · Ann Vasc Surg · 2021-02-06

本文综述了血液透析患者动静脉内瘘(AVF)相关高输出量心力衰竭(HOCF)的病理生理、风险分层与管理。AVF可致长期血流动力学改变,增加心输出量并最终引发心衰;男性、近端AVF及容量超负荷为相关风险因素,TIMP-4、Sirtuin-1/3表达失调及β肾上腺素受体系统性别差异参与其中。多种生物标志物及风险分层模型展现潜力,管理选项包括AVF结扎、束带术及吻合口成形术,但各具风险。

要点

  • AVF相关HOCF的病理生理涉及长期血流动力学改变、基因表达失调及性别差异。
  • 男性、近端AVF和容量超负荷是AVF术后HOCF的相关风险因素。
  • 心脏肌钙蛋白T/I、ANP、BNP等生物标志物有预后和诊断潜力,但临床效用待验证。

核心结论

  • AVF相关HOCF的病理生理复杂多因素,风险分层模型及生物标志物有望革新识别与管理,但需进一步研究验证临床效用。

研究设计与样本

  • 本文为综述,检索范围未在摘要中报告。

主要发现

  • AVF可致长期血流动力学改变,增加心输出量并导致心衰。
  • 男性、近端AVF及容量超负荷状态与AVF术后HOCF发展相关。
  • TIMP-4、Sirtuin-1和Sirtuin-3基因表达失调与心衰发展相关。
  • 性别差异归因于β肾上腺素受体系统活性改变。
  • 心脏肌钙蛋白T和I、ANP、BNP等生物标志物显示预后和诊断潜力。

临床怎么用

  • 临床可关注男性、近端AVF及容量超负荷等高危患者,并探索生物标志物及风险分层模型的应用。

局限性

  • 生物标志物在AVF相关HOCF患者中的临床效用需进一步研究确立。
  • AVF结扎、束带术及吻合口成形术等管理选项本身伴随相关风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

High-output cardiac failure is a rare form of heart failure associated with the formation of arteriovenous fistula (AVF) in hemodialysis patients. The pathophysiology underlying the HOCF is complex and multifactorial. Presence of AVF can cause long term hemodynamic changes that ultimately lead to increased cardiac output and consequently cardiac failure. A number of risk factors have been associated with the development of HOCF post-AVF construction, including male sex, a proximally located AVF and a state of volume overload. Dysregulation of tissue inhibitor of matrix metalloproteinase 4, Sirtuin-1 and Sirtuin-3 gene expression have been associated with the development of heart failure. The differences observed between genders have been attributed to altered activity of the β-adrenoceptor system. Numerous biomarkers including cardiac troponin T and I, atrial natriuretic peptide, brain natriuretic peptide among others have shown both prognostic and diagnostic potential; however further research is needed to establish their utility in clinical practice for patients with AVF associated HOCF. In recent years risk stratification models have been developed to help identify patients at the highest risk of developing HOCF post AVF which could be revolutionary in its identification and management. Potential options for managing HOCF post-AVF include AVF ligation, banding and anastoplasty however these procedures are not without their own associated risks. In this review, we discuss the pathophysiology, risk stratification and management of patients with AVF associated HOCF.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Zahra SA, Choudhury RY, Basharat K, et al. Translational Sciences in Cardiac Failure Secondary to Arteriovenous Fistula in Hemodialysis Patients. Ann Vasc Surg. 2021. PMID: 33556504. doi:10.1016/j.avsg.2021.01.071

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。